Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Embody vs Healthicare

Embody
Graded #52

Higher grade

vs+11
Healthicare
Graded #216

Lower grade

The verdict

Embody takes it — 76.5/100 to 65.5/100.

Embody grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEmbody +30
88
58
Dose & formulationHealthicare +5
83
88
Clinical oversightEmbody +12
83
71
Labs & monitoringEmbody +1
54
53
FulfillmentEmbody +31
93
62
Contract termsHealthicare +22
25
47
Embody · left barHealthicare · right bar

The numbers

MetricEmbodyHealthicare
WeighScore76.5/10065.5/100
GradeCC
Scorecard rank#52#216
Semaglutide$79/mo (all doses, promotional rate, compounded)$174/mo (compounded)
Tirzepatide$129/mo (all doses, promotional rate, compounded)$264/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Embody

Graded #52 · C

Strengths

  • Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Where it loses points

  • The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Healthicare

Graded #216 · C

Strengths

  • Both compounded and full brand-name menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
  • Pharmacy partner named publicly: Jungle Jim's Pharmacy (F&F Pharmacies Inc.), Fairfield, OH
  • Clinical lead named publicly: Dr. Jonah Mink, Beluga Health
  • Compounded semaglutide from $147.90/mo on the 3-month plan ($174/mo billed monthly) — lower end of the segment

Where it loses points

  • Not available in several states including CA, NV, NJ, NC, TX, MA — verify your state first
  • Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above cash retail; value is on the compounded tier
  • Footer references 'Sunshine Health Studios Inc.' — relationship to the domain owner is unclear

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard